CAS: 15837-41-9; 5-Hydroxypyrimidin-4(3H)-One

该化合物是一个环环氧有机化合物,在5 位置用一个火水晶核心替换成一个氢氧基,在4 位置用一个基质组替换成一个基质组.这个结构具有多功能性,使它成为制药和农用化学合成中宝贵的中间体.它的陶化特性和参加氢联结的能力增强了其在分子识别和协调化学中的效用.该化合物在温和条件下的稳定性和与一系列合成变异的兼容性进一步凸显了其在药用化学和材料科学中的重要性.其定义明确的化学行为有利于对定向应用做出精确的修改.

结构式图片

相似化合物

6623-81-0 6623-81-0 4763-35-3

上下游产品

CAS号91138-06-6 5-(苄氧基)嘧啶-4-醇

合成工艺路线路线简述

  • 合成目标产物 5-Hydroxy-1,4-Dihydropyrimidin-4-One 主要起始原料 4(1H)-Pyrimidinone, 2,3-Dihydro-5-[(Tetrahydro-2H-Pyran-2-yl)Oxy]-2-Thioxo-
  • (文献来源)合成步骤主要原料 4(1H)-Pyrimidinone, 2,3-Dihydro-5-[(Tetrahydro-2H-Pyran-2-yl)Oxy]-2-Thioxo-
📜2-Sulfanyl-5-(Tetrahydro-2H-Pyran-2-Yloxy)Pyrimidin-4(3H)-One置于ammonium Hydroxide,镍体系中,用 水 用作溶剂,化学反应 4.0H,以46%的收率获得5-羟基-4(1H)-嘧啶酮
参考文献:An Autoxidation Study Of C2 Substituted Pyrimidine Amino Reductones
标题:An Autoxidation Study Of C2 Substituted Pyrimidine Amino Reductones
摘要:Three Pyrimidine Derivatives (8A-C),Differing From Isouramil And Divicine At C2,Have Been Synthesized And Their Autoxidation Rates Measured Spectrophotometrically. The Autoxidation Rates Of All Five Pyrimidines (8A-C,Isouramil And Divicine) Were Correlated With Sigma(+)(P) Values (Rho=-1.28,R(2)=0.949). (C) 2006 Published By Elsevier Ltd.
Doi:10.1016/j.Tet.2006.03.049

海关参考信息

专利信息


专利号:US-2010008874-A1
优先权日:2006-04-11
标 题:Substituted pyrimidines, process for their production and their use as effective absorbents of uv irradiation
发明人:CLAES ENK DAVID; SREBNIK MORRIS
权利人:YISSUM RES DEV CO
摘要:The present invention discloses substituted pyrimidines, processes for their synthesis and their use as effective sun-protecting agents either alone or in combination with other known sun-protecting agents.

专利号:JP-2000281611-A
优先权日:1999-03-30
标 题 :Synthesis of phenolic compound having protected hydroxy group, and radioactive ray-sensitive composition by using the same

专利号:WO-2017156194-A1
优先权日:2016-03-08
标题:Compositions and methods for inhibiting influenza rna polymerase pa endonuclease
发明人:PUERTA DAVID T; COHEN SETH M; CREDILLE CY V
权利人:UNIV CALIFORNIA; PUERTA DAVID T
摘要:There are provided inter alia metalloenzyme inhibitors, such as inhibitors of influenza A RNA dependent RNA polymerase PA subunit endonuclease, and methods of synthesis and use of the same.

专利号:US-10889556-B2
优先权日:2016-03-08
标题 :Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
发明人:COHEN SETH M; CREDILLE CY V; PUERTA DAVID T
权利人:UNIV CALIFORNIA
摘要:There are provided inter alia metalloenzyme inhibitors, such as inhibitors of influenza A RNA dependent RNA polymerase PA subunit endonuclease, and methods of synthesis and use of the same.

专利号:WO-2021127273-A1
优先权日:2019-12-20
标题:1 -((6-oxo-1,6-dihydropyridazin-4-yl)methyl)piperazine and 1 -((6-oxo-1,6-dihydropyrimidin-4-yl)methyl)piperazine derivatives as prolyl hydroxylase, hif-1 alpha and pgk modulators for use in treating inflammatory diseases, cancer or infections
发明人:COBURN CRAIG; ROWBOTTOM MARTIN W
权利人:GB004 INC
摘要:Described herein are compounds of formulae (I), (lla) and (Mb) as prolyl hydroxylase inhibitors, HIF-lalpha stabilizers and PGK up regulators for use in treating inflammatory diseases, cancer or infections: Preferred compounds are e.g. tert-butyl-4-((l-benzyl-6-oxo-l,6- dihydropyridazin-4-yl)methyl)piperazine-l-carboxylate and tert-butyl-4-((l-benzyl-6-oxo-l,6-dihydropyrimidin-4-y I) methyl) piperazine-l-carboxylate derivatives and related compounds. Exemplary compounds are e.g. compound 1A: and compound 2A: The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 22 to 25 and 55 to 70; examples 1 to 5; compounds 1A to 2V; tables 1 and 2).

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:A. Albert and J. N. Phillips. J. Chem. Soc. 1956, 1294.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知